AGOMELATINE

Clinical Indication

Depression

Comments

Full SCA

Date of classification

July 2009

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.